Related references
Note: Only part of the references are listed.Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs
Bharath Srinivasan et al.
MEDICINAL RESEARCH REVIEWS (2019)
In Silico Study Probes Potential Inhibitors of Human Dihydrofolate Reductase for Cancer Therapeutics
Rabia Mukhtar Rana et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis
Allen T. Hopper et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Targeting species specific amino acid residues: Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors and potential anti-opportunistic infection agents
Khushbu Shah et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Expression, purification, and inhibition profile of dihydrofolate reductase from the filarial nematode Wuchereria bancrofti
Andrew M. Tobias et al.
PLOS ONE (2018)
Genetic markers in methotrexate treatments
Andrea Giletti et al.
PHARMACOGENOMICS JOURNAL (2018)
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus
Michele Tonelli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido[3,2-d]pyrimidines as potential nonclassical lipophilic antifolates targeting dihydrofolate reductase
Meng Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis of 2,4-Diaminopyrimidine Core-Based Derivatives and Biological Evaluation of Their Anti-Tubercular Activities
Yifan Ouyang et al.
MOLECULES (2017)
A putative multi-replicon plasmid co-harboring beta-lactamase genes blaKPC-2, blaCTX-M-14 and blaTEM-1 and trimethoprim resistance gene dfrA25 from a Klebsiella pneumoniae sequence type (ST) 11 strain in China
Yu Tang et al.
PLOS ONE (2017)
Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities
Sampark S. Thakkar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitors
Yomna I. El-Gazzar et al.
BIOORGANIC CHEMISTRY (2017)
Design, synthesis, antibacterial activity and docking study of some new trimethoprim derivatives
Umer Rashid et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Structural analysis of dihydrofolate reductases enables rationalization of antifolate binding affinities and suggests repurposing possibilities
Amrisha Bhosle et al.
FEBS JOURNAL (2016)
Charged Propargyl-Linked Antifolates Reveal Mechanisms of Antifolate Resistance and Inhibit Trimethoprim-Resistant MRSA Strains Possessing Clinically Relevant Mutations
Stephanie M. Reeve et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Charged Nonclassical Antifolates with Activity Against Gram-Positive and Gram-Negative Pathogens
Eric Scocchera et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Discovery of Potent and Selective Leads against Toxoplasma gondii Dihydrofolate Reductase via Structure-Based Design
Matthew E. Welsch et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates
Michael N. Lombardo et al.
ACS INFECTIOUS DISEASES (2016)
Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis
Behnoush Hajian et al.
PLOS ONE (2016)
MRSA Isolates from United States Hospitals Carry dfrG and dfrK Resistance Genes and Succumb to Propargyl-Linked Antifolates
Stephanie M. Reeve et al.
CELL CHEMICAL BIOLOGY (2016)
Modified 2,4-diaminopyrimidine-based dihydrofolate reductase inhibitors as potential drug scaffolds against Bacillus anthracis
Baskar Nammalwar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase
Bharath Srinivasan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Insights into the slow-onset tight-binding inhibition of Escherichia coli dihydrofolate reductase: detailed mechanistic characterization of pyrrolo [3,2-f] quinazoline-1,3-diamine and its derivatives as novel tight-binding inhibitors
Bharath Srinivasan et al.
FEBS JOURNAL (2015)
New small-molecule inhibitors of dihydrofolate reductase inhibit Streptococcus mutans
Qiong Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Identification of dfrA14 in two distinct plasmids conferring trimethoprim resistance in Actinobacillus pleuropneumoniae
Janine T. Bosse et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Nonracemic Antifolates Stereoselectively Recruit Alternate Cofactors and Overcome Resistance in S. aureus
Santosh Keshipeddy et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
The molecular epidemiology of incident methicillin-resistant Staphylococcus aureus cases among hospitalized patients in Alberta, Canada: a retrospective cohort study
Kathryn Bush et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2015)
Factors That Cause Trimethoprim Resistance in Streptococcus pyogenes
Rene Bergmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Crystal Structures of Klebsiella pneumoniae Dihydrofolate Reductase Bound to Propargyl-Linked Antifolates Reveal Features for Potency and Selectivity
Kristen M. Lamb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Updated Guidelines From the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America
Henry Masur et al.
CLINICAL INFECTIOUS DISEASES (2014)
Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
The BpeEF-OprC Efflux Pump Is Responsible for Widespread Trimethoprim Resistance in Clinical and Environmental Burkholderia pseudomallei Isolates
Nicole L. Podnecky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
First Three-Dimensional Structure of Toxoplasma gondii Thymidylate Synthase-Dihydrofolate Reductase: Insights for Catalysis, Interdomain Interactions, and Substrate Channeling
Hitesh Sharma et al.
BIOCHEMISTRY (2013)
Dihydropteroate synthase mutations in Pneumocystis pneumonia: impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohort
Christina Yoon et al.
MEDICAL MYCOLOGY (2013)
Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria
Jessica T. Lin et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2013)
Determinants of Quinolone versus Trimethoprim-Sulfamethoxazole Use for Outpatient Urinary Tract Infection
Anna K. Stuck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
First Detection of Trimethoprim Resistance Determinant dfrG in Streptococcus pyogenes Clinical Isolates in India
Rene Bergmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited
Gunnar Kahlmeter et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Mechanism Inspired Development of Rationally Designed Dihydrofolate Reductase Inhibitors as Anticancer Agents
Palwinder Singh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Toward New Therapeutics for Skin and Soft Tissue Infections: Propargyl-Linked Antifolates Are Potent Inhibitors of MRSA and Streptococcus pyogenes
Kishore Viswanathan et al.
PLOS ONE (2012)
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
Yongyuth Yuthavong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Designed Multiple Ligands for Cancer Therapy
N. M. O'Boyle et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Antifolate agents: a patent review (2006-2010)
Dennis L. Wright et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
2,4-Diamino-5-(2′-arylpropargyl)pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition
Oztekin Algul et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2011)
In Vitro Effect of Sulfamethoxazole-Trimethoprim against Histoplasma capsulatum var. capsulatum
Raimunda Samia Nogueira Brilhante et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Dihydrofolate Reductase Gene Variations in Susceptibility to Disease and Treatment Outcomes
Bahram S. Askari et al.
CURRENT GENOMICS (2010)
Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase
Kathleen M. Frey et al.
JOURNAL OF STRUCTURAL BIOLOGY (2010)
Predicting resistance mutations using protein design algorithms
Kathleen M. Frey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Iclaprim, a Novel Diaminopyrimidine for the Treatment of Resistant Gram-Positive Infections
Carrie A. Sincak et al.
ANNALS OF PHARMACOTHERAPY (2009)
In Vitro Bactericidal Activity of Iclaprim in Human Plasma
Heike Laue et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Probing the Active Site of Candida glabrata Dihydrofolate Reductase with High Resolution Crystal Structures and the Synthesis of New Inhibitors
Jieying Liu et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity
Christian Oefner et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Design, Synthesis, and X-ray Crystal Structure of Classical and Nonclassical 2-Amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as Dual Thymidylate Synthase and Dihydrofolate Reductase Inhibitors and as Potential Antitumor Agents
Aleem Gangjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Crystal Structures of Wild-type and Mutant Methicillin-resistant Staphylococcus aureus Dihydrofolate Reductase Reveal an Alternate Conformation of NADPH That May Be Linked to Trimethoprim Resistance
Kathleen M. Frey et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim
Holly Heaslet et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
Structure-Guided Development of Efficacious Antifungal Agents Targeting Candida glabrata Dihydrofolate Reductase
Jieying Liu et al.
CHEMISTRY & BIOLOGY (2008)
Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy
Kurt G. Naber et al.
EUROPEAN UROLOGY (2008)
Synthetic and Crystallographic Studies of a New Inhibitor Series Targeting Bacillus anthracis Dihydrofolate Reductase
Jennifer M. Beierlein et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Antimalarial activity of 2,4-diaminopyrimidines
J. Morgan et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2008)
Congenital toxoplasmosis: Priorities for further health promotion action
H. M. Elsheikha
PUBLIC HEALTH (2008)
Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men
J. Andrews et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection
Ying Taur et al.
CLINICAL INFECTIOUS DISEASES (2007)
Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis
Phillip M. Pelphrey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Antifolates as antimycotics?: Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans
Maria Dolores Navarro-Martinez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
New insights into DHFR interactions:: Analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(ω-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions
Vivian Cody et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada
MT Blahna et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The benefits of the multi-target approach in drug design and discovery
LM Espinoza-Fonseca
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Towards species-specific antifolates
DCM Chan et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Designed multiple ligands. An emerging drug discovery paradigm
R Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454)
J Sekiguchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with ω-carboxyalkoxy or ω-carboxy-1-alkynyl substitution in the side chain
DCM Chan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Integrons and gene cassettes in clinical isolates of co-trimoxazole-resistant Gram-negative bacteria
M Grape et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium
RA Forsch et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Antimicrobial dihydrofolate reductase inhibitors achievements and future options: Review
RL Then
JOURNAL OF CHEMOTHERAPY (2004)
Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance
L Huang et al.
EMERGING INFECTIOUS DISEASES (2004)
Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening
PC Wyss et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Further studies on 2,4-Diamino-5-(2′,5′-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS
A Rosowsky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Synthesis of new 2,4-diaminopyrido[2,3-d]pyrimidine and 2,4-diaminopyrrolo[2,3-d]pyrimidine inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductase
A Rosowsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project
G Kahlmeter
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria
P Schneider et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Atovaquone/Proguanil - A review of its use for the prophylaxis of Plasmodium falciparum malaria
K McKeage et al.
DRUGS (2003)
Development and effects of immunoliposomes carrying an antisense oligonucleotide against DHFR RNA and directed toward human breast cancer cells overexpressing HER2
M Rodríguez et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2002)
Inhibitors of dihydrofolate reductase in leishmania and trypanosomes
IH Gilbert
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species
J Afeltra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum
B Tarnchompoo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-[ω-carboxyalkyloxy)benzyl]pyrimidines:: Marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim
A Rosowsky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Synthesis and testing of 5-benzyl-2,4-diaminopyrimidines as potential inhibitors of leishmanial and trypanosomal dihydrofolate reductase
SF Chowdhury et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2002)
Dicyclic and tricyclic diaminopyrimidine derivatives as potent inhibitors of Cryptosporidium parvum dihydrofolate reductase:: Structure-activity and structure-selectivity correlations
RG Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Integrons and gene cassettes in the Enterobacteriaceae
PA White et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Prevention of invasive aspergillosis in AIDS by sulfamethoxazole
J Afeltra et al.
AIDS (2001)
The prevalence of trimethoprim-resistance-conferring dihydrofolate reductase genes in urinary isolates of Escherichia coli in Korea
JC Lee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Multiple mutations modulate the function of dihydrofolate reductase in trimethoprim-resistant Streptococcus pneumoniae
JP Maskell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Experimental in vitro efficacy study on the interaction of epiroprim plus isoniazid against Mycobacterium tuberculosis
M Dosso et al.
CHEMOTHERAPY (2001)
Share Paper
